Quick Answer
Hinge Health, Inc. reported Cash and Equivalents of $208.00 million for fiscal year 2025.
Hinge Health, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $208.00M | -30.8% |
| 2024 | $300.79M | +28.0% |
| 2023 | $234.95M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $261.34M | -2.3% | +10.2% |
| June 30, 2025 | $237.17M | +0.2% | -21.1% |
| December 31, 2024 | $300.79M | — | +12.4% |
| September 30, 2024 | $267.53M | — | +13.1% |
| June 30, 2024 | $236.63M | — | — |
- Hinge Health, Inc. showed a decrease of -30.8% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2023–2025 period, Hinge Health, Inc.’s cash and equivalents has declined by 11.5% (from $234.95 million to $208.00 million).
- The most recent figure is from Hinge Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: